Integrin-targeted stabilized nanoparticles for an efficient delivery of siRNAs in vitro and in vivo

Methods in Molecular Biology

Volumn 820, Issue , 2012, Pages 105-116

  Srinivasan, Charudharshini ^a,b,c   Peer, Dan ^d   Shimaoka, Motomu ^a  

^a CENTER FOR BLOOD RESEARCH   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d TEL AVIV UNIVERSITY   (Israel)

Author keywords

Antibody; Hyaluronan; Inflammation; Leukocytes; Liposomes; RNAi; Systemic delivery; Transfection

Indexed keywords

HYALURONIC ACID; INTEGRIN; LIPOSOME; NANOPARTICLE; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; C57BL MOUSE; CHEMISTRY; GENE VECTOR; GENETIC TRANSFECTION; GENETICS; HUMAN; LEUKOCYTE; METABOLISM; MOUSE; MOUSE MUTANT; RNA INTERFERENCE;

ANIMALS; GENETIC VECTORS; HUMANS; HYALURONIC ACID; INTEGRINS; LEUKOCYTES; LIPOSOMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NANOPARTICLES; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84555195893     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-61779-439-1_7     Document Type: Article

References (22)

1. Morrissey, D. V., Lockridge, J. A., Shaw, L., Blanchard, K., Jensen, K., Breen, W., Hartsough, K., Machemer, L., Radka, S., Jadhav, V., Vaish, N., Zinnen, S., Vargeese, C., Bowman, K., Shaffer, C. S., Jeffs, L. B., Judge, A., MacLachlan, I., Polisky, B. (2005) Potent and persistent in vivo anti-HBV activity of chemically modifi ed siRNAs. Nat. Biotechnol. 23: 1002-1007. (Pubitemid 41114035)
2. Zimmermann, T. S., Lee, A. C., Akinc, A., Bramlage, B., Bumcrot, D., Fedoruk, M. N., Harborth, J., Heyes, J. A., Jeffs, L. B., John, M., Judge, A. D., Lam, K., McClintock, K., Nechev, L. V., Palmer, L. R., Racie, T., Rohl, I., Seiffert, S., Shanmugam, S., Sood, V., Soutschek, J., Toudjarska, I., Wheat, A. J., Yaworski, E., Zedalis, W., Koteliansky, V., Manoharan, M., Vornlocher, H. P., MacLachlan, I. (2006) RNAi-mediated gene silencing in non-human primates. Nature 441: 111-114.
3. Akinc, A., Zumbuehl, A., Goldberg, M., Leshchiner, E. S., Busini, V., Hossain, N., Bacallado, S. A., Nguyen, D. N., Fuller, J., Alvarez, R., Borodovsky, A., Borland, T., Constien, R., de Fougerolles, A., Dorkin, J. R., Narayanannair Jayaprakash, K., Jayaraman, M., John, M., Koteliansky, V., Manoharan, M., Nechev, L., Qin, J., Racie, T., Raitcheva, D., Rajeev, K. G., Sah, D. W., Soutschek, J., Toudjarska, I., Vornlocher, H. P., Zimmermann, T. S., Langer, R., Anderson, D. G. (2008) A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat. Biotechnol. 26: 561-569. (Pubitemid 351668042)
4. Khan, A., Benboubetra, M., Sayyed, P. Z., Ng, K. W., Fox, S., Beck, G., Benter, I. F., Akhtar, S. (2004) Sustained polymeric delivery of gene silencing antisense ODNs, siRNA, DNAzymes and ribozymes: in vitro and in vivo studies. J. Drug Target. 12: 393-404. (Pubitemid 39302465)
5. Kawakami, S., Hashida, M. (2007) Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab. Pharmacokinet. 22: 142-151.
6. Dykxhoorn, D. M., Lieberman, J. (2005) The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu. Rev. Med. 56: 401-423. (Pubitemid 40299790)
7. Akhtar, S., Benter, I. F. (2007) Nonviral delivery of synthetic siRNAs in vivo. J. Clin. Invest. 117: 3623-3632. (Pubitemid 350224068)
8. Hu-Lieskovan, S., Heidel, J. D., Bartlett, D. W., Davis, M. E., Triche, T. J. (2005) Sequencespecifi c knockdown of EWS-FLI1 by targeted, nonviral delivery of small interfering RNA inhibits tumor growth in a murine model of metastatic Ewing's sarcoma. Cancer Res. 65: 8984-8992. (Pubitemid 41377390)
9. Song, E., Zhu, P., Lee, S. K., Chowdhury, D., Kussman, S., Dykxhoorn, D. M., Feng, Y., Palliser, D., Weiner, D. B., Shankar, P., Marasco, W. A., Lieberman, J. (2005) Antibody mediated in vivo delivery of small interfering RNAs via cell-surface receptors. Nat. Biotechnol. 23: 709-717. (Pubitemid 41716361)
10. Pirollo, K. F., Rait, A., Zhou, Q., Hwang, S. H., Dagata, J. A., Zon, G., Hogrefe, R. I., Palchik, G., Chang, E. H. (2007) Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system. Cancer Res. 67: 2938-2943. (Pubitemid 46724828)
11. Behlke, M. A. (2006) Progress towards in vivo use of siRNAs. Mol. Ther. 13: 644-670.
12. Goffi net, C., Keppler, O. T. (2006) Effi cient nonviral gene delivery into primary lymphocytes from rats and mice. Faseb J. 20: 500-502. (Pubitemid 46671229)
13. Marodon, G., Mouly, E., Blair, E. J., Frisen, C., Lemoine, F. M., Klatzmann, D. (2003) Specifi c transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene. Blood 101: 3416-3423. (Pubitemid 36857923)
14. Zhang, Y., Lu, H., LiWang, P., Sili, U., Templeton, N. S. (2003) Optimization of gene expression in nonactivated circulating lymphocytes. Mol. Ther. 8: 629-636. (Pubitemid 37321692)
15. Lai, W., Chang, C. H., Farber, D. L. (2003) Gene transfection and expression in resting and activated murine CD4 T cell subsets. J. Immunol. Methods 282: 93-102. (Pubitemid 37357036)
16. Song, E., Lee, S. K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., Lieberman, J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9: 347-351. (Pubitemid 36362792)
17. Peer, D., Park, E. J., Morishita, Y., Carman, C. V., Shimaoka, M. (2008) Systemic leukocytedirected siRNA delivery revealing cyclin D1 as an anti-infl ammatory target. Science 319: 627-630. (Pubitemid 351197066)
18. Peer, D., Zhu, P., Carman, C. V., Lieberman, J., Shimaoka, M. (2007) Selective gene silencing in activated leukocytes by targeting siRNAs to the integrin lymphocyte function-associated antigen-1. Proc. Natl. Acad. Sci. USA 104: 4095-4100. (Pubitemid 47181584)
19. Luo, B. H., Carman, C. V., Springer, T. A. (2007) Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25: 619-647. (Pubitemid 46697919)
20. Zhu, J., Carman, C. V., Kim, M., Shimaoka, M., Springer, T. A., Luo, B. H. (2007) Requirement of alpha and beta subunit transmembrane helix separation for integrin outsidein signaling. Blood 110: 2475-2483. (Pubitemid 47523169)
21. Peer, D., Shimaoka, M. (2009) Systemic siRNA delivery to leukocyte-implicated diseases. Cell Cycle 8: 853-859.
22. Kim, S. S., Peer, D., Kumar, P., Subramanya, S., Wu, H., Asthana, D., Habiro, K., Yang, Y. G., Manjunath, N., Shimaoka, M., Shankar, P. (2010) RNAi-mediated CCR5 silencing by LFA-1-targeted nanoparticles prevents HIV infection in BLT mice Mol. Ther. 18: 370-376.